Megadodo Publications
[MDET]
Home
Books
Holdings
Risk
Methodology
About
$565.60
+38.9%
Book Record · Feb 2026
Blood Music
Greg Bear
Read on Substack ↗
View Meetup ↗
Investment Record
Themes
CRISPR
In Vivo Gene Editing
Biotech
Tickers
NTLA
Trade date
2026-02-09
In vivo CRISPR as the dawn of personalized self-replicating biological medicine. NTLA (Intellia) as primary position.
Book Club Ratings
6.2
avg · 15 raters
0
1
2
1
3
3
4
4
5
6
1
7
3
8
3
9
10